Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Two MIT Professors Named Howard Hughes Medical Institute Investigators

Published: Friday, May 10, 2013
Last Updated: Friday, May 10, 2013
Bookmark and Share
Peter Reddien and Aviv Regev are among 27 top biomedical scientists selected nationwide.

Two members of the MIT faculty — Peter Reddien and Aviv Regev — have been named Howard Hughes Medical Institute (HHMI) investigators, bringing the total number of MIT professors who hold the distinction to 18.

Selected for their scientific excellence, HHMI investigators remain at their home institutions, but HHMI pays their salaries and funds much of their research. This gives the investigators freedom to explore, change direction in their research and see their ideas through to fruition — even if that process takes many years. Reddien and Regev will begin their five-year HHMI appointments in September.

“HHMI has a very simple mission,” HHMI President Robert Tjian said in announcing the new investigators. “We find the best original-thinking scientists and give them the resources to follow their instincts in discovering basic biological processes that may one day lead to better medical outcomes. This is a very talented group of scientists. And while we cannot predict where their research will take them, we’re eager to help them move science forward.”

Reddien and Regev were among 27 biomedical scientists selected as new HHMI investigators from 1,155 applicants. HHMI currently supports approximately 330 investigators throughout the country, including 15 Nobel laureates and more than 150 members of the National Academy of Sciences.

Peter Reddien

Peter Reddien is an associate professor of biology and associate head of MIT’s Department of Biology. He is also a member of the Whitehead Institute for Biomedical Research, an associate member of the Broad Institute and an HHMI Early Career Scientist.

Reddien’s work centers on the study of planaria, flatworms that have regenerative abilities. His lab seeks to identify and understand the molecular and cellular mechanisms that control these worms’ regeneration. His group discovered that planaria are equipped with stem cells that have the capacity to become any type of cell in their bodies — and that these cells create new tissue during regeneration.

Reddien continues to investigate the sources of planaria’s regenerative powers. His insights may lead to new understanding of the genes and pathways that control tissue repair and stem cells in humans. His work may also help reveal the limits of the human body to regenerate lost or injured tissue.

Aviv Regev

Aviv Regev is an associate professor of biology at MIT. She is also a core faculty member and director of the Klarman Cell Observatory at the Broad Institute and an HHMI Early Career Scientist.

Regev uses computational and experimental approaches to investigate how molecular networks that regulate gene activity respond to genetic and environmental changes — in the short term and over millennia. She has developed, among other things, techniques to analyze how yeast genes and regulatory networks have changed over 300 million years and how circuits change as immune cells respond to pathogens.

Additionally, her lab is using advanced experimental techniques, such as inserting genes into cells with silicon nanowires, to chart the molecular circuitry of T cells. Her algorithms are used in labs around the world to analyze gene expression data and other information.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Viruses Join Fight Against Harmful Bacteria
Engineered viruses could combat human disease and improve food safety.
Friday, September 25, 2015
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Tuesday, September 22, 2015
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Tuesday, September 22, 2015
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Thursday, August 27, 2015
A Metabolic Master Switch Underlying Human Obesity
Researchers find pathway that controls metabolism by prompting fat cells to store or burn fat.
Friday, August 21, 2015
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Friday, July 31, 2015
Firms “Under-invest” in Long-Term Cancer Research
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Thursday, July 30, 2015
Nanoparticles Can Clean Up Environmental Pollutants
Researchers have found that nanomaterials and UV light can “trap” chemicals for easy removal from soil and water.
Thursday, July 23, 2015
Researchers Develop Genetic Tools to Engineer Common Gut Bacterium
Researchers from the Massachusetts Institute of Technology have developed genetic parts that can be combined to program the commensal gut bacterium Bacteroides thetaiotaomicron.
Friday, July 10, 2015
Longstanding Problem Put to Rest
Proof that a 40-year-old algorithm for comparing genomes is the best possible will come as a relief to computer scientists.
Thursday, June 11, 2015
Diagnosing Cancer with Help from Bacteria
Engineered probiotics can detect tumors in the liver.
Friday, May 29, 2015
Master Gene Regulator Could Be New Target For Schizophrenia Treatment
Researchers at MIT’s Picower Institute for Learning and Memory have identified a master genetic regulator that could account for faulty brain functions that contribute to schizophrenia.
Wednesday, May 27, 2015
Brain Tumor Weakness Identified
Discovery could offer a new target for treatment of glioblastoma.
Thursday, April 09, 2015
New Nanodevice Defeats Drug Resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Wednesday, March 04, 2015
New Nanodevice Defeats Drug Resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Tuesday, March 03, 2015
Scientific News
Gene Editing Could Enable Pig-To-Human Organ Transplant
The largest number of simultaneous gene edits ever accomplished in the genome could help bridge the gap between organ transplant scarcity and the countless patients who need them.
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
UC San Diego Team Up with Illumina to Speed-Read Your Microbiome
Data analysis app accelerates studies aimed at using microbes to predict, diagnose and treat human diseases.
Paving the Way for Diamonds to Trace Early Cancers
Researchers from the University of Sydney reveal how nanoscale 'diamonds' can light up early-stage cancers in MRI scans.
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Chromosomal Chaos
Penn study forms basis for future precision medicine approaches for Sezary syndrome
Shaking Up the Foundations of Epigenetics
Researchers at the Centre for Genomic Regulation (CRG) and the University of Barcelona (UB) published a study that challenges some of the current beliefs about epigenetics.
Genetic Defences of Bacteria Don’t Aid Antibiotic Resistance
Genetic responses to the stresses caused by antibiotics don’t help bacteria to evolve a resistance to the medications, according to a new study by Oxford University researchers.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos